310 related articles for article (PubMed ID: 24135254)
1. Immunogenicity of a modified intradermal pre-exposure rabies vaccination schedule using a purified chick embryo cell vaccine: an observational study.
Lau CL; Hohl N
Travel Med Infect Dis; 2013; 11(6):427-30. PubMed ID: 24135254
[TBL] [Abstract][Full Text] [Related]
2. Intradermal pre-exposure rabies immunisation in New Zealand.
Shaw MM; Leggat PA; Williams ML
Travel Med Infect Dis; 2006 Jan; 4(1):29-33. PubMed ID: 16887722
[TBL] [Abstract][Full Text] [Related]
3. The immunogenicity of a modified intradermal pre-exposure rabies vaccination schedule--a case series of 420 travelers.
Mills DJ; Lau CL; Fearnley EJ; Weinstein P
J Travel Med; 2011; 18(5):327-32. PubMed ID: 21896096
[TBL] [Abstract][Full Text] [Related]
4. Rabies post-exposure prophylaxis vaccination with purified chick embryo cell vaccine (PCECV) and purified Vero cell rabies vaccine (PVRV) in a four-site intradermal schedule (4-0-2-0-1-1): an immunogenic, cost-effective and practical regimen.
Ambrozaitis A; Laiskonis A; Balciuniene L; Banzhoff A; Malerczyk C
Vaccine; 2006 May; 24(19):4116-21. PubMed ID: 16545510
[TBL] [Abstract][Full Text] [Related]
5. A randomized open-labeled study to demonstrate the non-inferiority of purified chick-embryo cell rabies vaccine administered in the Zagreb regimen (2-1-1) compared with the Essen regimen in Chinese adults.
Ma J; Wang H; Li J; Chang L; Xie Y; Liu Z; Zhao Y; Malerczyk C
Hum Vaccin Immunother; 2014; 10(10):2805-12. PubMed ID: 25483635
[TBL] [Abstract][Full Text] [Related]
6. A single center, open label study of intradermal administration of an inactivated purified chick embryo cell culture rabies virus vaccine in adults.
Recuenco S; Warnock E; Osinubi MOV; Rupprecht CE
Vaccine; 2017 Aug; 35(34):4315-4320. PubMed ID: 28688782
[TBL] [Abstract][Full Text] [Related]
7. Antibody response of patients after postexposure rabies vaccination with small intradermal doses of purified chick embryo cell vaccine or purified Vero cell rabies vaccine.
Briggs DJ; Banzhoff A; Nicolay U; Sirikwin S; Dumavibhat B; Tongswas S; Wasi C
Bull World Health Organ; 2000; 78(5):693-8. PubMed ID: 10859864
[TBL] [Abstract][Full Text] [Related]
8. Pre-exposure rabies vaccination using purified chick embryo cell rabies vaccine intradermally is immunogenic and safe.
Kamoltham T; Thinyounyong W; Phongchamnaphai P; Phraisuwan P; Khawplod P; Banzhoff A; Malerczyk C
J Pediatr; 2007 Aug; 151(2):173-7. PubMed ID: 17643772
[TBL] [Abstract][Full Text] [Related]
9. Rabies pre-exposure vaccination of children with purified chick embryo cell vaccine (PCECV).
Malerczyk C; Vakil HB; Bender W
Hum Vaccin Immunother; 2013 Jul; 9(7):1454-9. PubMed ID: 23571224
[TBL] [Abstract][Full Text] [Related]
10. Reduced dose pre-exposure primary and booster intradermal rabies vaccination with a purified chick embryo cell vaccine (PCECV) is immunogenic and safe in adults.
Roukens AH; Vossen AC; van Dissel JT; Visser LG
Vaccine; 2008 Jun; 26(27-28):3438-42. PubMed ID: 18511158
[TBL] [Abstract][Full Text] [Related]
11. Simulated post-exposure rabies vaccination with purified chick embryo cell vaccine using a modified Thai Red Cross regimen.
Madhusudana SN; Sanjay TV; Mahendra BJ; Suja MS
Int J Infect Dis; 2004 May; 8(3):175-9. PubMed ID: 15109593
[TBL] [Abstract][Full Text] [Related]
12. Comparative evaluation of immunogenicity, reactogenecity and safety of purified chick embryo cell rabies vaccine and neural tissue rabies vaccine.
Deshpande AK; Londhe VA; Akarte S; Briggs D
J Assoc Physicians India; 2003 Jul; 51():655-8. PubMed ID: 14621031
[TBL] [Abstract][Full Text] [Related]
13. Rabies neutralizing antibody after 2 intradermal doses on days 0 and 21 for pre-exposure prophylaxis.
Wongsaroj P; Udomchaisakul P; Tepsumethanon S; Khawplod P; Tantawichien T
Vaccine; 2013 Mar; 31(13):1748-51. PubMed ID: 23370149
[TBL] [Abstract][Full Text] [Related]
14. Boosting effect of purified chick embryo cell rabies vaccine using the intradermal route in persons previously immunized by the intramuscular route or vice versa.
Sudarshan MK; Madhusudana SN; Mahendra BJ; Narayana DH; Giri MS; Muhamuda K; Ravish HS; Venkatesh GM
Natl Med J India; 2006; 19(4):192-4. PubMed ID: 17100105
[TBL] [Abstract][Full Text] [Related]
15. The effectiveness of intradermal pre-exposure rabies vaccination in an Australian travel medicine clinic.
Lau C; Sisson J
J Travel Med; 2002; 9(6):285-8. PubMed ID: 12962581
[TBL] [Abstract][Full Text] [Related]
16. Human rabies prevention--United States, 2008: recommendations of the Advisory Committee on Immunization Practices.
Manning SE; Rupprecht CE; Fishbein D; Hanlon CA; Lumlertdacha B; Guerra M; Meltzer MI; Dhankhar P; Vaidya SA; Jenkins SR; Sun B; Hull HF;
MMWR Recomm Rep; 2008 May; 57(RR-3):1-28. PubMed ID: 18496505
[TBL] [Abstract][Full Text] [Related]
17. Preexposure Intradermal Rabies Vaccination: A Noninferiority Trial in Healthy Adults on Shortening the Vaccination Schedule From 28 to 7 Days.
Soentjens P; Andries P; Aerssens A; Tsoumanis A; Ravinetto R; Heuninckx W; van Loen H; Brochier B; Van Gucht S; Van Damme P; Van Herrewege Y; Bottieau E
Clin Infect Dis; 2019 Feb; 68(4):607-614. PubMed ID: 29939243
[TBL] [Abstract][Full Text] [Related]
18. Early rabies antibody response to intramuscular booster in previously intradermally immunized travelers using human diploid cell rabies vaccine.
Gherardin AW; Scrimgeour DJ; Lau SC; Phillips MA; Kass RB
J Travel Med; 2001; 8(3):122-6. PubMed ID: 11468113
[TBL] [Abstract][Full Text] [Related]
19. A pilot study on intradermal vaccination of Japanese rabies vaccine for pre-exposure immunization.
Shiota S; Khawplod P; Ahmed K; Mifune K; Nishizono A
Vaccine; 2008 Nov; 26(50):6441-4. PubMed ID: 18804510
[TBL] [Abstract][Full Text] [Related]
20. [Comparative immunogenicity of 2 antirabies vaccines in a 2-1-1 post-exposure vaccination schedule].
Landry P; Lazzaro M; Darioli R
Praxis (Bern 1994); 1998 Sep; 87(37):1177-9. PubMed ID: 9785997
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
